Effects of TNT on Pain, ROM and Disability in Patients With RC Tendinopathy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorRiphah International University

About this trial

EFFECTS OF TENDON NEUROPLASTIC TRAINING ON PAIN, RANGE OF MOTION AND DISABILITY IN PATIENTS WITH ROTATOR CUFF TENDINOPATHY

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Have a current shoulder complaint lasting at least three months prior to the time of enrollment

Pain is located in the proximal lateral aspect of the upper arm (C5 dermatome)

Positive Hawkins-Kennedy test

Disqualifiers

Bilateral shoulder pain

Less than 90 degrees of active elevation of the arm

Corticosteroid injection within the last six weeks

Radiologically verified fracture

Trial design

Design model

Parallel

Treatments tested in this trial

  • tendon neuroplastic training

    Other intervention

    Throughout the training, participants pain, range of motion and disability were monitored and they were asked to report any discomfort or unusual sign.

  • conventional training

    Other intervention

    Throughout the training, participants pain, range of motion and disability were monitored and they were asked to report any discomfort or unusual sign.

Treatment groups

38 Participants
are divided into 2 treatment groups
Group A: Tendon neuroplastic trainingExperimental treatment 1 intervention
Group B: Conventional trainingActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Numeric pain rate scale (NPRS)

Patient level of pain will be assessed using this scale. This scale ranges from 0 to 10. 0 indicates "no pain" and 10 indicates "worst pain".

Time frame
6 weeks
2

Shoulder pain and disability index (spadi)

Patient level of disability will be assessed using this scale. This ranges from 0 to 100. 0 indicates no disability" and 100 indicates disability"

Time frame
6 weeks
3

Universal Goniometer (UG)

It will measure range of motion of shoulder

Time frame
6 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.